Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP) Save

Date Added
October 18th, 2016
PRO Number
Pro00057768
Researcher
Benjamin Toll
Keywords
Lung, Smoking
Summary

Smoking cessation is the most important strategy available to reduce lung cancer risk. To date, there has been no research on tobacco cessation in lung screening patients, who may have unique attributes (e.g., anxiety about having a nodule coupled with tobacco dependence). We thus propose to evaluate 2 novel behavioral interventions as adjuncts to standard pharmacotherapy. We will enroll and randomize 276 patients undergoing lung screening to Intervention 1 (gain-framed personalized video and print intervention). We will evaluate whether this will improve tobacco quit rates above and beyond standard of care smoking cessation treatment over 8 weeks. Then we will perform a second randomization to Intervention 2, an individual-level, biofeedback intervention. We will then evaluate whether this intervention will reduce smoking rates at 6 months.

Institution
MUSC
Recruitment Contact
Nortorious Coleman
843-509-7589
colemann@musc.edu

Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs Save

Date Added
June 21st, 2016
PRO Number
Pro00055397
Researcher
Benjamin Toll
Keywords
Lung, Pulmonary, Smoking
Summary

This research is a randomized smoking cessation trial conducted within and specifically personalized for lung cancer screening patients presenting to a lung screening clinic. Novel tobacco treatments for this population are critically needed, given the growing population of lung screening patients. In the proposed study, we will test a gain-framed messaging intervention specifically designed for lung screening patients (vs. unframed messaging), as well as evaluating NRT sampling (vs. no medication).

Institution
MUSC
Recruitment Contact
Nortorious Coleman
843-509-7589
colemann@musc.edu

Novel Treatment to Enhance Smoking Cessation before Cancer Surgery Save

Date Added
April 21st, 2015
PRO Number
Pro00043340
Researcher
Benjamin Toll
Keywords
Cancer
Summary

This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.

Institution
MUSC
Recruitment Contact
Alana Rojewski
unknown
rojewski@musc.edu

Change_preferences

-- OR --

Create_login